Insights on Life Sciences


Resilience in life sciences: Emerging stronger from the downturn

– As the life sciences industry is tested by an uncertain economic environment, companies can focus not only on resilience but on positioning themselves to accelerate when coming out of the downturn.

Steadfast but nimble: CEO Christi Shaw on cancer treatment’s cutting edge

– Kite’s CEO discusses the company’s CAR T-cell therapies and what it means to put patients first.
Interview - McKinsey Health Institute

‘Stay grounded, stay humble’: Sanofi CEO Paul Hudson

– In the wake of the COVID-19 pandemic, one of the first non-French leaders of the pharmaceutical company Sanofi explains cultural... transformations, the growth of AI in decision making, and how he stays humble.

Europe’s Bio Revolution: Biological innovations for complex problems

– Advances in biological science could help the world overcome its most pressing challenges in health and sustainability. Europe’s... Bio Revolution could translate scientific strengths into impact.

AI for medtech commercial growth: Five missteps to avoid

– Medtech companies are looking to AI and advanced analytics to help retool their commercial models to meet customers’ evolving... expectations—but common misunderstandings can delay progress.

The Next Normal – The future of biotech: AI-driven drug discovery

– Many diseases today don’t have a cure. One reason is that drug discovery is difficult: finding and developing an effective... medicine is a yearslong and very expensive process. But maybe it doesn’t have to be. Experts say AI—if properly integrated into scientists’ research—could revolutionize drug discovery, making it possible for more patients to get the treatments they need.

How AI can accelerate R&D for cell and gene therapies

– Cell and gene therapies show significant promise but need substantial innovation to unlock full potential for patients. Scaling... digital and analytics in discovery and R&D is part of the solution.

Putting the patient first: A conversation with Roche’s Moritz Hartmann

– The global head of information solutions for a leading healthcare provider explains the importance of technological and management... innovation in helping to serve patients in new ways.

The Helix report: Is biopharma wired for future success?

– The biopharmaceutical industry has made remarkable achievements in the past decade, but is it equipped to leap still further ahead... in the coming one? Company leaders’ answers to nine questions could prove decisive.

Special collection

Future of pharma operations

Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations.

Coronavirus vaccines progress: What’s next?

The rapid development of the COVID-19 vaccines is having a profound effect on the world. This collection takes a closer look at the development, rollout and future of vaccines.

McKinsey insights on cell and gene therapy

Continuing advances in cell and gene therapy (CGT) are transforming how biopharma companies treat and potentially cure certain diseases. Browse our collection of articles for an in-depth look at the opportunities, challenges, and implications for stakeholders in this fast-evolving field, and explore how McKinsey’s new Digital Capability Center for Cell and Gene Therapy will help biopharma companies accelerate digital transformations in manufacturing and the journey to operational excellence. Contact us to learn more.

The rise of health technology

Health technology continues to push the boundaries of how healthcare is delivered and has the power to create breakthroughs in our understanding of disease. This collection of articles and interviews explores the evolving role of health technology in the life-sciences sector and implications for key stakeholders. Contact us to learn more about our work in this field.

Want to learn more about how we help clients in Life Sciences?

More insights


How Daiichi Sankyo Europe drives growth with digital and analytics

– Digital and analytics can markedly improve life sciences companies’ engagement with customers. Daiichi Sankyo Europe’s... CEO Jan Van Ruymbeke explains the challenges to adopting digital and analytics and how his company overcame them.

How sterile pharma manufacturers can grow capacity without capital investment

– The world will need more sterile products than manufacturers have or can build capacity for. But they can create capacity and... take market share by running higher volumes through their existing lines.

Pursuing quantum in pharma with purpose: An interview with Boehringer Ingelheim’s CTO

– Clemens Utschig-Utschig discusses how his company is exploring quantum computing for its potential to propel next-generation drug... discovery.

Quarterly value releases: Transforming pharma through digital and analytics—fast

– Life sciences companies can struggle to capture the power of digital and analytics in their labs and clinical programs. A new... approach to implementing change that insists on value every 90 days could prove pivotal.

How AI could revolutionize drug discovery

– Artificial intelligence could help scientists develop better medicines faster—and thus improve millions of people’s... lives. But for that to happen, companies will need to change the way they work.

Vineeta Agarwala on the promise—and limits—of AI in drug discovery

– By helping us learn from every single patient and every piece of data, AI could enable medical breakthroughs, says Andreessen... Horowitz general partner Vineeta Agarwala.

‘It will be a paradigm shift’: Daphne Koller on machine learning in drug discovery

– We’re entering a “new era of science”—we finally have enough data and technology to truly enable better... drugs for patients, says insitro CEO Daphne Koller.

‘We can invent new biology’: Molly Gibson on the power of AI

– The cofounder of Generate Biomedicines, a pioneering new drug development platform, describes how AI and machine learning are... transforming the way we discover new medicines.

Building greater resilience in vaccine manufacturing

– The COVID-19 pandemic has highlighted the need for resilience in vaccine manufacturing. Five considerations can help national public-health... leaders plan.

How the European biotech sector can navigate turbulent times

– The recent market downturn has affected biotechs worldwide. But the fundamentals are still strong in Europe, where companies have... an opportunity to lead the next phase of bioscience innovation.

Reimagining the future of biopharma manufacturing

– Leveraging digital and analytics advances can unlock significant value for biopharma companies through gains in quality, speed,... agility, and resilience.
Sorry, we couldn't find any results. Try removing some filters.

Related Practices

Healthcare Systems & Services

Read our latest research, articles, and reports on Healthcare Systems & Services on the changes that matter most for the challenges... and opportunities ahead.

Consumer Health

The consumer-health industry is booming, driven by an aging population, a proliferation of wellness-related products and services,... burgeoning sources of health-related information, and consumers’ desire to control their health.

Public & Social Sector

Read our latest research, articles, and reports on Public & Social Sector.

Connect with our Life Sciences Practice